John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 39,511 shares at $38.32 ($1.6M) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Open-market sale of $1.6M VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.54 | 327 | $11K | 0.7% |
| 2 | $34.72 | 142 | $5K | 0.3% |
| 3 | $35.27 | 20 | $705 | 0.0% |
| 4 | $38.32 | 2,266 | $87K | 5.5% |
| 5 | $38.32 | 2,266 | $87K | 5.5% |
| 6 | $39.33 | 1,563 |
| $61K |
| 3.9% |
| 7 | $39.33 | 1,563 | $61K | 3.9% |
| 8 | $39.96 | 15,682 | $627K | 40.0% |
| 9 | $39.96 | 15,682 | $627K | 40.0% |
| Total | $39.65 avg | 39,511 | $1.6M | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |